Seven Fleet Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Seven Fleet Capital Management's AXSM Position: Q3 2026 in Review
Seven Fleet Capital Management reduced its Axsome Therapeutics (AXSM) stake by 17% in Q3 2026, selling an estimated $1.04M and leaving 24,066 shares worth $4.44M. The position accounts for 0.87% of the portfolio, ranked #19.
Seven Fleet Capital Management first reported a position in AXSM in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.06M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Seven Fleet Capital Management held 24,066 shares of Axsome Therapeutics worth $4.44M as of Q3 2026.
- Seven Fleet Capital Management sold 4,760 Axsome Therapeutics shares in Q3 2026, an estimated $1.04M.
- Axsome Therapeutics made up 0.87% of Seven Fleet Capital Management's portfolio in Q3 2026, its #19 holding.
- Seven Fleet Capital Management first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Seven Fleet Capital Management's Axsome Therapeutics position peaked at $7.06M in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.